SecSonar.com

Bioventus Inc. (BVS)

Bioventus Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Bioventus Inc. (BVS) is a Medical - Devices company based in US with a market capitalization of $580.6M. Revenue declined 0.9% year-over-year and the company generated $71.4M in free cash flow. This page tracks BVS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 930 employees · IPO Feb 11, 2021

Valuation

Valuation & price

$10.58 · as of May 17, 2026 · -3.3% vs 52w high

32.1

P/E ratio

Latest-FY diluted EPS

3.15

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.94$8.62$6.30Jul 25Dec 25Jul 26Jul 7, 25$6.82Jul 9, 25$7.32Jul 11, 25$6.97Jul 15, 25$6.60Jul 17, 25$6.49Jul 21, 25$6.30Jul 23, 25$6.47Jul 25, 25$6.57Jul 29, 25$6.54Jul 31, 25$6.52Aug 4, 25$6.32Aug 6, 25$7.29Aug 11, 25$6.93Aug 13, 25$7.53Aug 15, 25$7.37Aug 19, 25$7.32Aug 21, 25$7.08Aug 25, 25$7.44Aug 27, 25$7.49Aug 29, 25$7.40Sep 3, 25$7.04Sep 5, 25$7.19Sep 9, 25$7.27Sep 11, 25$7.28Sep 16, 25$6.84Sep 18, 25$7.20Sep 22, 25$6.94Sep 24, 25$6.89Sep 26, 25$6.66Sep 30, 25$6.69Oct 2, 25$6.71Oct 6, 25$6.79Oct 8, 25$6.76Oct 10, 25$6.51Oct 14, 25$6.68Oct 16, 25$6.88Oct 21, 25$7.12Oct 23, 25$6.96Oct 27, 25$6.71Oct 29, 25$6.77Oct 31, 25$6.55Nov 4, 25$7.55Nov 6, 25$7.48Nov 10, 25$7.49Nov 12, 25$7.65Nov 14, 25$7.35Nov 18, 25$6.99Nov 20, 25$6.53Nov 25, 25$7.79Nov 28, 25$7.59Dec 2, 25$7.56Dec 4, 25$7.62Dec 8, 25$7.19Dec 10, 25$7.50Dec 12, 25$7.55Dec 16, 25$7.52Dec 18, 25$7.70Dec 22, 25$7.48Dec 24, 25$7.38Dec 29, 25$7.53Jan 2, 26$7.21Jan 6, 26$7.65Jan 8, 26$8.00Jan 12, 26$7.75Jan 14, 26$7.74Jan 16, 26$7.93Jan 21, 26$8.00Jan 23, 26$8.02Jan 27, 26$7.92Jan 29, 26$7.82Feb 2, 26$8.21Feb 4, 26$8.10Feb 9, 26$8.52Feb 11, 26$8.08Feb 13, 26$8.27Feb 18, 26$8.49Feb 20, 26$8.58Feb 24, 26$8.72Feb 26, 26$8.86Mar 2, 26$8.77Mar 4, 26$8.47Mar 6, 26$8.41Mar 10, 26$8.86Mar 12, 26$8.60Mar 17, 26$8.99Mar 19, 26$9.00Mar 23, 26$9.00Mar 25, 26$9.16Mar 27, 26$8.94Mar 31, 26$9.13Apr 2, 26$8.97Apr 7, 26$8.84Apr 9, 26$9.10Apr 13, 26$9.42Apr 15, 26$10.56Apr 17, 26$10.52Apr 22, 26$9.77Apr 24, 26$10.09Apr 28, 26$9.96Apr 30, 26$9.87May 4, 26$10.17May 6, 26$10.92May 8, 26$10.50May 12, 26$10.14May 14, 26$10.61May 18, 26$10.63May 20, 26$10.94May 22, 26$9.28May 28, 26$8.87Jun 1, 26$7.93Jun 3, 26$8.55Jun 5, 26$9.04Jun 9, 26$9.20Jun 11, 26$8.68Jun 15, 26$8.60Jun 17, 26$8.54Jun 22, 26$8.79Jun 24, 26$9.50Jun 26, 26$9.78Jul 2, 26$10.30
$6.1452-week range$10.94
Loading valuation history…

Fundamentals

Key fundamentals

$580.6M

Market cap

-0.9%

Revenue growth (YoY)

67.3%

Gross margin

$71.4M

Free cash flow (USD)

$260.1M

Net debt

1.9%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$274.5MFY 2017$292.1MFY 2018$319.2MFY 2019$340.1MFY 2020$321.2MFY 2021$430.9MFY 2022$512.1MFY 2023$512.3MFY 2024$573.3MFY 2025$568.1M
$274.5M$568.1M

Free cash flow by year

2018 → 2025

FY 2018$39.1MFY 2019$32.4MFY 2020$51.1MFY 2021$2.1MFY 2022$-15.0MFY 2023$8.0MFY 2024$37.8MFY 2025$71.4M
$39.1M$71.4M

Gross margin by year

2021 → 2025

FY 202170.3%FY 202264.7%FY 202364.1%FY 202467.7%FY 202567.3%
70.3%67.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 4, 2026Filing
  • 8-K eventFDA ReclassificationMay 21, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is Bioventus Inc.'s market cap?

Bioventus Inc. (BVS) has a market capitalization of $580.6M.

What is BVS's P/E ratio?

BVS trades at a price-to-earnings ratio of 32.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is BVS's price-to-book (P/B) ratio?

BVS trades at 3.15 times book value per share.

Are insiders buying BVS stock?

SEC Form 4 filings show no open-market insider buys at Bioventus Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

NPCE

NeuroPace, Inc.

$590.8M

TCMD

Tactile Systems Technology, Inc.

$560.5M

CTKB

Cytek Biosciences, Inc.

$551.6M

CERS

Cerus Corporation

$612.8M

BWAY

BrainsWay Ltd.

$613.4M

SIBN

SI-BONE, Inc.

$631.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.